JACC: CardioOncology
Издатель: Elsevier · ISSN 2666-0873 · 46 статей
- Cancer Outcomes in Cardiovascular Trials of Inflammation-Targeting Therapeutics: JACC CardioOncology Primer
- Inflammatory Cell Profiles in Early- and Late-Manifestation Immune Checkpoint Inhibitor Myocarditis
- Timing the Myocardial Inflammatory Consequences of ICI Immunotherapy
- Fibrotic Rewiring of CD8+ T Cells by Doxorubicin Drives Pathological Remodeling of Cardiac Extracellular Matrix
- CD8+ T Cells in Doxorubicin Cardiotoxicity: From Immune Activation to Matrix Remodeling
- High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors
- Know Your Denominator: Troponin T/I Discordance in Immune Checkpoint Inhibitor-Treated Cancer Patients
- Disseminated Lymphoplasmacytic Lymphoma to the Sympathetic Chain Causing VT Storm
- Fatal Coronary and Mesenteric Vasculopathy With Immune Checkpoint Inhibitor Therapy
- Potential Ascertainment Bias and Event Adjudication in T Cell Engager–Associated Cardiovascular Event Reporting
- Reply: Potential Ascertainment Bias and Event Adjudication in T Cell Engager–Associated Cardiovascular Event Reporting
- Immunology and Cardio-Oncology
- Full Issue PDF
- Cardiovascular Toxicity of CDK4/6 Inhibitors in Breast Cancer: JACC: CardioOncology Primer
- Factors Associated With Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis
- Association of Life's Essential 8 With Clonal Hematopoiesis and Coronary Artery Disease